Abstract
Reduction of dopamine concentrations in the brains of patients with Parkinsonism, together with reported clinical improvement after the administration of dihydroxyphenylalanine, has led to the hypothesis that impaired hydroxylation of tyrosine may be associated with the disease. To test this hypothesis oral loading tests with L-phenylalanine and tyrosine were carried out in patients and controls. After phenylalanine lower blood levels of this were found in Parkinsonian patients than in controls, but tyrosine levels were the same. After tyrosine lower levels of this were also found in patients compared with controls. It is suggested that these findings indicate a decreased rate of tyrosine utilization in Parkinson's disease together with intestinal malabsorption; the latter is supported by the finding of abnormal D-xylose tolerance in these patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARBEAU A., MURPHY G. F., SOURKES T. L. Excretion of dopamine in diseases of basal ganglia. Science. 1961 May 26;133(3465):1706–1707. doi: 10.1126/science.133.3465.1706-a. [DOI] [PubMed] [Google Scholar]
- BUTTERWORTH C. E., Jr, PEREZ-SANTIAGO E., MARTINEZ DE JESUS J., SANTINI R. Studies on the oral and parenteral administration of D (+) xylose. N Engl J Med. 1959 Jul 23;261(4):157–164. doi: 10.1056/NEJM195907232610401. [DOI] [PubMed] [Google Scholar]
- Besser G. M. Tyrosine tolerance in thyroid disease. Clin Sci. 1968 Oct;35(2):171–176. [PubMed] [Google Scholar]
- Boulton A. A., Pollitt R. J., Majer J. R. Identity of a urinary "pink spot" in schizophrenia and Parkinson's disease. Nature. 1967 Jul 8;215(5097):132–134. doi: 10.1038/215132a0. [DOI] [PubMed] [Google Scholar]
- Cotzias G. C., Van Woert M. H., Schiffer L. M. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967 Feb 16;276(7):374–379. doi: 10.1056/NEJM196702162760703. [DOI] [PubMed] [Google Scholar]
- HORNYKIEWICZ O. [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease]. Wien Klin Wochenschr. 1963 May 3;75:309–312. [PubMed] [Google Scholar]
- Pelz K. S., Gottfried S. P., Soos E. Intestinal absorption studies in the aged. Geriatrics. 1968 Apr;23(4):149–153. [PubMed] [Google Scholar]
- RIVLIN R. S., MELMON K. L., SJOERDSMA A. AN ORAL TYROSINE TOLERANCE TEST IN THYROTOXICOSIS AND MYXEDEMA. N Engl J Med. 1965 Jun 3;272:1143–1148. doi: 10.1056/NEJM196506032722202. [DOI] [PubMed] [Google Scholar]
- WONG P. W., O'FLYNN M. E., INOUYE T. MICROMETHODS FOR MEASURING PHENYLALANINE AND TYROSINE IN SERUM. Clin Chem. 1964 Dec;10:1098–1104. [PubMed] [Google Scholar]